Research
Energy balance
Existing pharmacologic formulations for obesity have not provided optimal clinical efficacy and have had many concerning adverse effects.
Practitioners should be aware of the limitations and adverse effects of current obesity pharmacotherapies.
StrongSupportsmedium confidence
However, existing formulations have not provided optimal clinical efficacy and have had many concerning adverse effects.
Why this rating
The claim is based on a review of existing pharmacologic approaches.
Source
Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists
Merle Myerson et al. · The Journal of Clinical Pharmacology · 2024
DOI 10.1002/jcph.2487
reviewCited 17×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →